media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Kappac Pharma Ltd.
( in Crs.)

ParticularsMar 21Mar 20Mar 19Mar 18Mar 17
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRPRPRPRAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]0.000.001.000.000.00
Total Operating Revenues0.000.001.000.000.00
      
Other Income-2.170.000.000.000.00
Total Revenue-2.170.001.000.000.00
      
EXPENSES     
Purchase Of Stock-In Trade0.000.001.000.000.00
Employee Benefit Expenses0.010.010.000.000.00
Other Expenses0.010.000.050.010.04
Total Expenses0.030.021.050.010.04
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-2.20-0.02-0.05-0.01-0.04
      
Profit/Loss Before Tax-2.20-0.02-0.05-0.01-0.04
      
Tax Expenses-Continued Operations     
Profit/Loss After Tax And Before ExtraOrdinary Items-2.20-0.02-0.05-0.01-0.04
      
Profit/Loss From Continuing Operations-2.20-0.02-0.05-0.01-0.04
      
Profit/Loss For The Period-2.20-0.02-0.05-0.01-0.04
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-0.73-0.01-0.020.00-0.01
Diluted EPS (Rs.)-0.73-0.01-0.020.00-0.01
ParticularsMar 21
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]0.00
Total Operating Revenues0.00
Other Income-2.17
Total Revenue-2.17
EXPENSES 
Purchase Of Stock-In Trade0.00
Employee Benefit Expenses0.01
Other Expenses0.01
Total Expenses0.03
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-2.20
Profit/Loss Before Tax-2.20
Tax Expenses-Continued Operations 
Profit/Loss After Tax And Before ExtraOrdinary Items-2.20
Profit/Loss From Continuing Operations-2.20
Profit/Loss For The Period-2.20
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-0.73
Diluted EPS (Rs.)-0.73